Suez and GMCA have extended their waste and recycling contracts in the UK by eight years. The contracts are worth over 1 billion pounds and with this extension, Suez will provide waste management services until 2034.

Honeywell has joined hands with Chevron to develop advanced artificial intelligence-Assisted solutions which have the capacity to help plant operators to make decisions with regards to enhancing efficiency for refining processes and improving safety within the industrial automation space.

Achema has once again opened its doors to the global process industry. Located in Frankfurt, Germany, the mega show which will be held from June 10 – 14, 2024, offers six innovative themes – Process, Pharma, Green, Lab, Digital and Hydrogen.

Lyten has plans to invest more than 1 billion dollars to develop the world’s first Lithium-Sulfur battery Gigafactory in Nevada, USA. The facility is expected to produce up to 10 GWh of batteries annually at full scale.

Axium’s extensive expertise allows for the design and manufacture of crossflow membrane filtration solutions tailored for diverse applications, all while adhering to international regulations and maintaining the highest of hygienic standards.

OQ Chemicals has secured the Ecovadis Gold rating for the sixth consecutive year. The award recognizes innovations such as the ISCC Plus-certified Oxbalance product line and the company-wide ‘reduce’ initiative aimed at achieving climate neutrality, as well as OQ Chemicals’ high safety standards.

KBR’s green ammonia technology has been selected by Ocior Energy for its green ammonia plant in Odisha, India. On completion, the project is expected to have a capacity of 600 metric tons per day.

Cepsa has plans to invest 75-million-euros to develop Spain’s first isopropyl alcohol plant which will be used to produce hydroalcoholic gels. The plant will make use of green hydrogen and will replace fossil-based raw materials in the production of isopropyl alcohol with sustainable alternatives.

Marco Beyl and Johannes-Thomas Grobe have been appointed as CFO and CEO Pharma at Optima Group respectively. They will succeed their predecessors who will be continuing to support the company in an advisory capacity.

Innovation in high technology and Italian hospitality — now IMA Group rises the next level. Following acquisitions and in-house developments, IMA has evolved into a one-stop-shop supplier, says Thomas Fricke, Commercial Director o IMA Pharma. At Achema IMA presents a developement opening up the cell- and gene therapy market.